Press release
New drugs for Migraine excite: Key takeaway from Assessment Analysis
Migraine
Request a sample report @ https://www.htfmarketreport.com/sample-report/2361022-migraine-pipeline-review
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Pipeline Review, H2 2019, provides an overview of the Migraine (Central Nervous System) pipeline landscape.
Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of the head. These headaches are often associated with nausea, vomiting, and extreme sensitivity to light and sound. Symptoms include problems speaking, tingling in face, arms, and shoulders, pain behind one of the eyes and pain that gets worse with routine physical activity.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Migraine - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Migraine (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Migraine (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Migraine and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 15, 13, 12, 1, 30, 4 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 1, 2 and 2 molecules, respectively.
Migraine (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Companies Mentioned in the Report
Achelios Therapeutics Inc, Acorda Therapeutics Inc, Allergan Plc, Allodynic Therapeutics LLC, Amgen Inc, AOBiome LLC, Aptarion biotech AG, Asarina Pharma AB, Astrocyte Pharmaceuticals Inc, Avanir Pharmaceuticals Inc, Axsome Therapeutics Inc, Biohaven Pharmaceutical Holding Company Ltd, BioHealthonomics Inc, Blackthorn Therapeutics Inc, Cerecin Inc, CerSci Therapeutics Inc, Charleston Laboratories Inc, Citragen Pharmaceuticals Inc, Corium International Inc, Crossject SA, Curatis AG, CURx Pharmaceuticals Inc, DelNova Inc, Eli Lilly and Co, Epalex Corp, Exxel Pharma Inc, H. Lundbeck AS, Impel NeuroPharma Inc, InKemia IUCT Group SA, InStar Technologies AS, IntelGenx Corp, Invisio Ltd, Ionis Pharmaceuticals Inc, Klaria Pharma Holding AB, Lateral Pharma Pty Ltd, Living Cell Technologies Ltd, MannKind Corp, Medytox Inc, Merck & Co Inc, NAL Pharmaceuticals Ltd, NeurAxon Pharma Inc, NutriBand Inc, Old API Wind-down Ltd, OWP Pharmaceuticals Inc, Panaxia Pharmaceutical Industries Ltd, Pharmnovo AB, Pivot Pharmaceuticals Inc, Promius Pharma LLC, Qingdao Chia Tai Haier Pharmaceutical Co Ltd, RAFT Pharmaceuticals, Revance Therapeutics Inc, Sarfez Pharmaceuticals Inc, Satsuma Pharmaceuticals Inc, Seurat Therapeutics Inc, Shanghai Junshi Bioscience Co Ltd, Shin Nippon Biomedical Laboratories Ltd, Sorrento Therapeutics Inc, Sosei Heptares, Suda Pharmaceuticals Ltd, Terran Biosciences Inc, Teva Pharmaceutical Industries Ltd, Trevena Inc, TrioxBio Inc, Xenon Pharmaceuticals Inc, Xoc Pharmaceuticals Inc, Zosano Pharma Corp
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2361022-migraine-pipeline-review
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Migraine (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Migraine (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Migraine (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Migraine (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Migraine (Central Nervous System)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Migraine (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Migraine (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/2361022-migraine-pipeline-review
Table of Contents
Introduction
Migraine - Overview
Migraine - Therapeutics Development
Migraine - Therapeutics Assessment
Migraine - Companies Involved in Therapeutics Development
Migraine - Drug Profiles
Migraine - Dormant Projects
Migraine - Discontinued Products
Migraine - Product Development Milestones
AppendixList of Tables
Num
....Continued
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=2361022
Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA - 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
Connect with us at LinkedIn | Facebook | Twitter
About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the "Accurate Forecast" in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their "Goals & Objectives".
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New drugs for Migraine excite: Key takeaway from Assessment Analysis here
News-ID: 1908195 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
Digital lottery platforms Market Is Booming Worldwide | Major Giants Internation …
HTF MI recently introduced Global Digital lottery platforms Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Digital lottery platforms Market are:
Camelot Group, International Game Technology (IGT), Scientific Games, Intralot, Lottoland, Lotto Direct, Jumbo…
Graduation gifts Market Is Booming Worldwide | Major Giants Things Remembered, P …
HTF MI recently introduced Global Graduation gifts Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Graduation gifts Market are:
Amazon, Etsy, Hallmark, Things Remembered, Walmart, Nordstrom, Tiffany & Co., Pandora, Swarovski, Coach, Kate Spade,…
Luxury Home Decor Market Getting Back To Stellar Growth Ahead: Hermès, Fendi C …
The Latest Released Global Luxury Home Decor market study has evaluated the future growth potential of Global Luxury Home Decor market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along…
Sun Protection Sleeve Market Review: All Eyes on 2025 Outlook | Under Armour, Ni …
The Latest Released Global Sun Protection Sleeve market study has evaluated the future growth potential of Global Sun Protection Sleeve market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
